| Mutational heterogeneity in cancer and the search for new cancer-associated genes MS Lawrence, P Stojanov, P Polak, GV Kryukov, K Cibulskis, ... Nature 499 (7457), 214-218, 2013 | 6105 | 2013 |
| Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells RM Meyers, JG Bryan, JM McFarland, BA Weir, AE Sizemore, H Xu, ... Nature genetics 49 (12), 1779-1784, 2017 | 1762 | 2017 |
| Targeting MYCN in neuroblastoma by BET bromodomain inhibition A Puissant, SM Frumm, G Alexe, CF Bassil, J Qi, YH Chanthery, ... Cancer discovery 3 (3), 308-323, 2013 | 736 | 2013 |
| Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators H Hieronymus, J Lamb, KN Ross, XP Peng, C Clement, A Rodina, ... Cancer cell 10 (4), 321-330, 2006 | 697 | 2006 |
| Genomic copy number dictates a gene-independent cell response to CRISPR/Cas9 targeting AJ Aguirre, RM Meyers, BA Weir, F Vazquez, CZ Zhang, U Ben-David, ... Cancer discovery 6 (8), 914-929, 2016 | 695 | 2016 |
| The genomic landscape of pediatric Ewing sarcoma BD Crompton, C Stewart, A Taylor-Weiner, G Alexe, KC Kurek, ... Cancer discovery 4 (11), 1326-1341, 2014 | 549 | 2014 |
| Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies GS Cowley, BA Weir, F Vazquez, P Tamayo, JA Scott, S Rusin, ... Scientific data 1 (1), 1-12, 2014 | 492 | 2014 |
| TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia TW McLean, S Ringold, D Neuberg, K Stegmaier, R Tantravahi, J Ritz, ... | 422 | 1996 |
| An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia B Knoechel, JE Roderick, KE Williamson, J Zhu, JG Lohr, MJ Cotton, ... Nature genetics 46 (4), 364-370, 2014 | 403 | 2014 |
| The public repository of xenografts enables discovery and randomized phase II-like trials in mice EC Townsend, MA Murakami, A Christodoulou, AL Christie, J Köster, ... Cancer cell 29 (4), 574-586, 2016 | 354 | 2016 |
| Gene expression–based high-throughput screening (GE-HTS) and application to leukemia differentiation K Stegmaier, KN Ross, SA Colavito, S O'Malley, BR Stockwell, TR Golub Nature genetics 36 (3), 257-263, 2004 | 341 | 2004 |
| EWS–FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma A Gorthi, JC Romero, E Loranc, L Cao, LA Lawrence, E Goodale, ... Nature 555 (7696), 387-391, 2018 | 327 | 2018 |
| The genomic landscape of juvenile myelomonocytic leukemia E Stieglitz, AN Taylor-Weiner, TY Chang, LC Gelston, YD Wang, T Mazor, ... Nature genetics 47 (11), 1326-1333, 2015 | 294 | 2015 |
| A method for high-throughput gene expression signature analysis D Peck, ED Crawford, KN Ross, K Stegmaier, TR Golub, J Lamb Genome biology 7, 1-6, 2006 | 260 | 2006 |
| Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry AD Durbin, MW Zimmerman, NV Dharia, BJ Abraham, AB Iniguez, ... Nature genetics 50 (9), 1240-1246, 2018 | 252 | 2018 |
| Multicenter feasibility study of tumor molecular profiling to inform therapeutic decisions in advanced pediatric solid tumors: the individualized cancer therapy (iCat) study MH Harris, SG DuBois, JLG Bender, AR Kim, BD Crompton, E Parker, ... JAMA oncology 2 (5), 608-615, 2016 | 221 | 2016 |
| Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors M Aste-Amézaga, N Zhang, JE Lineberger, BA Arnold, TJ Toner, M Gu, ... PloS one 5 (2), e9094, 2010 | 221 | 2010 |
| Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules B Nabet, FM Ferguson, BKA Seong, M Kuljanin, AL Leggett, ML Mohardt, ... Nature communications 11 (1), 4687, 2020 | 212 | 2020 |
| Proteomic and genetic approaches identify Syk as an AML target CK Hahn, JE Berchuck, KN Ross, RM Kakoza, K Clauser, AC Schinzel, ... Cancer cell 16 (4), 281-294, 2009 | 189 | 2009 |
| In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling PG Miller, F Al-Shahrour, KA Hartwell, LP Chu, M Järås, RV Puram, ... Cancer cell 24 (1), 45-58, 2013 | 183 | 2013 |
